
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12091193
[patent_doc_number] => 20170348284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'USE OF MARIZOMIB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/611614
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 65235
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611614 | Use of marizomib for the treatment of central nervous system (CNS) cancers | May 31, 2017 | Abandoned |
Array
(
[id] => 12091193
[patent_doc_number] => 20170348284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'USE OF MARIZOMIB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/611614
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 65235
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611614 | Use of marizomib for the treatment of central nervous system (CNS) cancers | May 31, 2017 | Abandoned |
Array
(
[id] => 12091193
[patent_doc_number] => 20170348284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'USE OF MARIZOMIB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/611614
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 65235
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611614 | Use of marizomib for the treatment of central nervous system (CNS) cancers | May 31, 2017 | Abandoned |
Array
(
[id] => 12091193
[patent_doc_number] => 20170348284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'USE OF MARIZOMIB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/611614
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 65235
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611614 | Use of marizomib for the treatment of central nervous system (CNS) cancers | May 31, 2017 | Abandoned |
Array
(
[id] => 12627081
[patent_doc_number] => 20180100857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHOD OF USING NON-RARE CELLS TO DETECT RARE CELLS
[patent_app_type] => utility
[patent_app_number] => 15/601696
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601696 | METHOD OF USING NON-RARE CELLS TO DETECT RARE CELLS | May 21, 2017 | Abandoned |
Array
(
[id] => 17029744
[patent_doc_number] => 11091549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Single domain antibody and derivative proteins thereof against CTLA4
[patent_app_type] => utility
[patent_app_number] => 16/302583
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19286
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302583 | Single domain antibody and derivative proteins thereof against CTLA4 | May 18, 2017 | Issued |
Array
(
[id] => 11949522
[patent_doc_number] => 20170253670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'COMMON LIGHT CHAINS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/600015
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 66245
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600015 | COMMON LIGHT CHAINS AND METHODS OF USE | May 18, 2017 | Abandoned |
Array
(
[id] => 14537397
[patent_doc_number] => 20190204320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Methods of Predicting Responsiveness of a Cancer to a VEGF Targeting Agent and Methods of Prognosing and Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 16/302343
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302343 | Methods of predicting responsiveness of a cancer to a VEGF targeting agent and methods of prognosing and treating cancer | May 16, 2017 | Issued |
Array
(
[id] => 11943316
[patent_doc_number] => 20170247468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'COMPOSITIONS FOR INHIBITION OF QUIESCIN SULFHYDRYL OXIDASE (QSOX1) AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 15/494585
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 32132
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494585
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494585 | COMPOSITIONS FOR INHIBITION OF QUIESCIN SULFHYDRYL OXIDASE (QSOX1) AND USES OF SAME | Apr 23, 2017 | Abandoned |
Array
(
[id] => 14700153
[patent_doc_number] => 10377810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients
[patent_app_type] => utility
[patent_app_number] => 15/492535
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11102
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492535 | Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients | Apr 19, 2017 | Issued |
Array
(
[id] => 11980878
[patent_doc_number] => 20170285032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/487952
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487952 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER | Apr 13, 2017 | Abandoned |
Array
(
[id] => 12029589
[patent_doc_number] => 20170319688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'ANTI-RSPO3 ANTIBODIES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/486898
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 45187
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486898 | ANTI-RSPO3 ANTIBODIES AND METHODS OF USE | Apr 12, 2017 | Abandoned |
Array
(
[id] => 14214025
[patent_doc_number] => 20190119397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => PLECTIN-1 BINDING ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/091928
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -100
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091928 | Plectin-1 binding antibodies and uses thereof | Apr 6, 2017 | Issued |
Array
(
[id] => 11979354
[patent_doc_number] => 20170283508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Methods for Inhibiting Angiogenesis in a Subject in Need Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/476154
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 48481
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476154 | Methods for inhibiting angiogenesis in a subject in need thereof | Mar 30, 2017 | Issued |
Array
(
[id] => 11758545
[patent_doc_number] => 20170205414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'DIAGNOSTIC FOR COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/471147
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12553
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471147 | Diagnostic for colorectal cancer | Mar 27, 2017 | Issued |
Array
(
[id] => 13840621
[patent_doc_number] => 20190023795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => FUSION PROTEINS TARGETING TUMOUR ASSOCIATED MACROPHAGES FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/085126
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085126 | Fusion proteins targeting tumour associated macrophages for treating cancer | Mar 15, 2017 | Issued |
Array
(
[id] => 12052563
[patent_doc_number] => 20170328907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'PODOCALYXIN AND TRA-RELATED ANTIBODY, METHODS OF PREPARATION AND USES AS AN ANTI-CANCER THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/457050
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5878
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457050
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457050 | Podocalyxin and TRA-related antibody, methods of preparation and uses as an anti-cancer therapeutic agent | Mar 12, 2017 | Issued |
Array
(
[id] => 12346893
[patent_doc_number] => 09951134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Modified J-chain
[patent_app_type] => utility
[patent_app_number] => 15/452616
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 19
[patent_no_of_words] => 16941
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/452616 | Modified J-chain | Mar 6, 2017 | Issued |
Array
(
[id] => 11692347
[patent_doc_number] => 20170168058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/427883
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33681
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427883 | COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER | Feb 7, 2017 | Abandoned |
Array
(
[id] => 14516263
[patent_doc_number] => 10335365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Bladder cancer specific ligand peptides
[patent_app_type] => utility
[patent_app_number] => 15/400987
[patent_app_country] => US
[patent_app_date] => 2017-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 32
[patent_no_of_words] => 22019
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400987 | Bladder cancer specific ligand peptides | Jan 6, 2017 | Issued |